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Baeyer–Villiger monooxygenases (BVMOs) receive increasing attention as 
enzymes useful for biocatalytic applications. Industrial requirements call for rapid 
and extensive redesign of these enzymes. In response to the need of screening 
large libraries of BVMO mutants, we have established a generic screening method 
that allows screening Escherichia coli cells expressing BVMOs in 96­well plate for­
mat. For this, we first developed an expression system for production of phenyl­
acetone monooxygenase (PAMO) in the periplasm of E. coli. This allows probing 
the enzyme for any target substrate while it is also compatible with extracellular 
co enzyme regeneration. For coenzyme regeneration, we used phosphite dehy­
drogenase which forms phosphate upon NADPH recycling. This allowed usage 
of a chromogenic molybdate­based phosphate determination assay. The screen­
ing procedure was supplemented with a detection method for identification of 
mutant enzymes that act as NADPH oxidases, thereby excluding false positives. 
The whole­cell­based screening method was validated by screening site­satura­
tion libraries of PAMO and resulted in the identification of PAMO mutants with 
altered catalytic properties. This new method can be used for screening libraries 
of BVMOs for activity with any desired substrate and, therefore, is a powerful tool 
for engineering of these enzymes.
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Introduction
Baeyer–Villiger monooxygenases (BVMOs) are promising enzymes with respect 
to indus trial applications as they offer the possibility to perform, among others, 
oxygen atom insertion into a C–C bond and enantioselective sulfoxidations (Balke 
et al., 2012; Leisch et al., 2011). However, the properties of naturally occurring 
enzymes are typically far from the demands set by commercial processes. Features 
such as substrate acceptance, stereo selec ti vity, and stability need to be improved 
before these enzymes can be applied on industrial scale. Directed evolution is 
a powerful tool for engineering enzymes. Despite the potential significance of 
BVMOs, there have been only few examples of directed evolution experiments on 
this class of enzymes. In most of the reported studies, screening for BVMO variants 
with improved properties was performed using chromatographic methods such as 
GC (Clouthier et al., 2006; Reetz et al., 2004a; Reetz and Wu, 2008; Reetz and Wu, 
2009; Wu et al., 2010) or HPLC (Reetz et al., 2004b).Unfortunately, these screening 
methods are of limited throughput, demand establishing optimal separation con­
ditions for each targeted compound, and require specialised equipment. In addi­
tion, the adrenalin assay was applied in screening for enantioselective variants of 
a BVMO from Pseudomonas fluorescens DSM 50106 (Kirschner and Bornscheuer, 
2008). In this assay, the hydrolysis of Baeyer–Villiger products yielded 1,2­diols, 
which were then quantified in a colorimetric assay. Furthermore, Bornscheuer and 
co­workers used p­nitroacetophenone to detect 4­hydroxy aceto phenone mono­
oxygenase activity (Saß et al., 2012). In this assay, Baeyer–Villiger oxidation of the 
substrate and hydrolysis of the product lead to the formation of p­nitrophenolate. 
The assay was applied in screening libraries of 4­hydroxyacetophenone mono­
oxygenase mutants yielding variants with improved activity towards p­nitroaceto­
phenone. However, the latter two methods can only be used for specific substrates.
A few other methods for screening BVMOs have been described, for instance, 
a pH­change­based assay (Watts et al., 2002). This assay revolves around hydroly­
sis of the Baeyer–Villiger product, resulting in the release of acid. However, this 
assay requires extensive optimisation to give reliable signals and an esterase spe­
cific for the Baeyer–Villiger product. Furthermore, several fluoro genic methods, 
employing umbelliferone­labelled sub strates, have been used successfully for the 
detection of BVMOs (Gutiérrez et al., 2003; Sicard et al., 2005). The underlying 
principle of the latter methods is the Baeyer–Villiger oxidation of the umbellifer­
one­labelled substrate and subsequent hydrolysis of the Baeyer–Villiger product, 
resulting in the release of the fluorescent umbelliferone. A screening method for 
ketone biotransformations was also presented, which was used successfully for the 
detection of BVMO activity (Linares­Pastén et al., 2012). This method is based on 
the reaction between alicyclic ketones and 3,5­dinitrobenzoic acid under alkaline 
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conditions, resulting in the formation of a purple coloured product. Despite being 
fast and simple, this method requires relatively high activities, and it is limited 
to a certain class of compounds.
Although a variety of screening methods for the detection of BVMO activity 
has been described (see above), most of these methods have never been tested in 
BVMO­mutant­library screening, are of limited throughput, are designed for spe­
cific substrates, or require the synthesis of labelled substrates. The drawbacks of 
the current screening methods underscore the need of a generic, preferably high­
throughput, screening method for BVMO acti vity. Here we report on a screen­
ing method for NAD(P)­dependent enzymes, in particular BVMOs (Figure 1). 
This screening system was validated for phenyl acetone monooxy genase from 
Thermobifida fusca (PAMO, EC 1.14.13.92, Fraaije et al., 2005). We expressed 
PAMO in the periplasm of Escherichia coli to ensure the unlimited access of sub­
strates to the enzyme and to enable the shuttling of nicotinamide coenzymes 
between PAMO and exter nally added phosphite dehydrogenase (PTDH). The lat­
ter enzyme is required for NADPH regeneration (Torres Pazmiño et al., 2008). 
Coenzyme regeneration by PTDH results in phosphate as a side­product, which 
Figure 1. Schematic representation of the principle of the developed screening method. PAMO is 
translocated to the periplasm by the Tat trans porter. In the periplasm, PAMO performs the oxida­
tion of a substrate at the expense of NADPH. NADPH and NADP+ can freely diffuse into and out 
of the peri plasm. PTDH added to the reaction medium reduces NADP+ to NADPH while oxidising 
phosphite to phosphate. The concentration of the latter compound is measured in the reaction with 
molybdate by forming a blue product. Hydrogen peroxide, a product of the uncoupling reaction, is 
detected by fluorogenic Peroxy Green 1 (IM, inner membrane; OM, outer membrane).
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can be used as a reporter of Baeyer–Villiger activity. To quantify phosphate, we 
used a modified version of the molybdate assay (Saheki et al., 1985), which allows 
colorimetric detection. To increase the fidelity of our screening procedure, we 
in cluded a control reaction to exclude false positive clones. To this end, we detect 
hydrogen peroxide, which is typically produced during uncoupling of the BVMO 
reaction at the expense of NADPH and oxygen (Torres Pazmiño et al., 2008). 
The integration of periplasmic expression of PAMO, coenzyme regeneration, and 
spectro photometric detection of coupled products resulted in an accurate and 
reliable screening method, which can be applied to test monooxygenase activity 
on any desired substrate.
Materials and Methods
Enzymes, reagents, and strains. Unless indicated, all chemicals were obtained from Sigma­Aldrich, 
Acros Organics, TCI Europe, Roche Diagnostics GmbH, and Merck. PfuTurbo was purchased from 
Strategene (La Jolla, CA). Restriction enzymes were obtained from New England Biolabs (Ipswich, 
MA). In­Fusion 2.0 Dry­Down PCR Cloning Kit (Clontech, Mountain View, CA) was used for DNA 
cloning. dNTPs were ordered at Clontech. Nucleotide primers were purchased at Sigma. NADPH 
was purchased at Oriental Yeast Co. Ltd. (Tokyo, Japan). Sodium phosphite was obtained from 
Riedel de Haën (Seelze, Germany). Peroxy Green 1 was kindly provided by P. Wiegerinck (Organon, 
The Netherlands). E. coli TOP10 cells were obtained from Invitrogen. DNA sequencing was per­
formed at GATC Biotech (Konstanz, Germany). A modified low­phosphate AP5 medium (Chang 
et al., 1987) was used to grow E. coli cells expressing Tat­PAMO. The AP5 medium contained: NaCl 
(60  mm), KCl (10 mm), NH4Cl (20 mm), MgSO4 (1.6  mm), triethanolamine (150 mm, pH 7.4), 
glycerol (0.15% (v/v)), and N­Z­amine A from bovine milk (0.3% (w/v), Fluka). As compared to 
the original recipe, glucose was replaced by glycerol, and no phosphate source was added. ~0.3 mm 
phosphate present in the medium comes from casein hydrolysate N­Z­amine A. All reagents used 
in the screening were prepared using filtered water. Molybdate reagent was prepared by dissolving 
zinc acetate (100  mm, Fluka) and ammonium molybdate ((NH4)6Mo7O24•4H2O, 10 mm, Sigma) 
and adjusting pH to 5.0. The solution was stored at room temperature in a plastic bottle and was 
stable for at least six months. Ascorbic acid solution was prepared by dissolving l­(+)­ascorbic acid 
(10% (w/v), Sigma­Aldrich) and adjusting pH to 5.0. It was aliquoted and stored at –20 °C. Stock 
solutions of phenylacetone (1 m), benzyl phenyl sulfide (0.125 m), and Peroxy Green 1 (25 mm) were 
prepared by dissolving the respective compounds in 1,4­dioxane.
Subcloning, expression, and purification of PTDH. A codon­optimised thermostable variant of 
the ptxD gene was amplified from the pCRE2 vector (Torres Pazmiño et al., 2009) and subcloned 
into the same vector using NdeI/HindIII sites. This yielded the pPTDH plasmid in which ptxD gene 
is fused to an N­terminal His­tag. E. coli TOP10 cells were transformed with this plasmid and grown 
in LB supplemented with ampicillin (50 μg mL−1, LBAmp). The next day the cells were diluted (1:100) 
in Terrific Broth (TB) supplemented with ampicillin (50 μg mL−1) and l­arabinose (0.02% (w/v)) 
and incubated at 30 °C for 16 h. The protein was purified using Ni Sepharose High Performance (GE 
Healthcare Bio­Sciences AB, Uppsala, Sweden). Purified PTDH was flash­frozen with the addition 
of glycerol (10% (v/v)) and stored at −80 °C. The concentration of PTDH was determined using 
two assays: Waddell’s method (Waddell, 1956) and the estimated extinction coefficient at 280 nm 
(calculated using the ProtParam tool, http://web.expasy.org/protparam): ε280 nm = 26.5 mm−1 cm−1.
Construction of mutants and mutant libraries. Mutants of Tat­PAMO used as controls in the 
screening (R337A, M446G, Q152F, Q152F/L153G/M446G), as well as the site­saturation libraries 
I67X and M446X were constructed by QuikChange PCR using standard mutagenic primers and 
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following the manufacturer’s recommendation. The libraries were constructed by introduction of 
the NNK codon at the respective positions.
Export of PAMO to the periplasm. The pamO gene was cloned into the previously described 
pBAD­Tat­AldO plasmid (van Bloois et al., 2009) via EcoRI and HindIII sites, replacing the aldO 
sequence in the vector. In this way, the pamO gene was fused to an N­terminal signal sequence from 
E. coli TorA protein and a C­terminal Myc epitope/His­tag. E. coli TOP10 cells were transformed 
with the Tat­PAMO plasmid. In order to test whether PAMO was present in the periplasm, the 
cells harbouring Tat­PAMO plasmid were grown in LBAmp supplemented with l­arabinose (0.0002–
0.005% (w/v)) at 17 °C or 24 °C for 48 h and at 37 °C for 16 h, and subsequently fractionated with 
the help of PeriPreps PeriPlasting kit (Epicentre Biotechnologies, Madison, WI). Specific activity of 
PAMO in spheroplast and periplasmic fractions was measured using the NADPH depletion activity 
assay while Bradford assay (Bio­rad, Hercules, CA) was employed to assess the protein content in 
the samples. In the NADPH depletion assay, the reaction mix contained phenylacetone (1 mm), 
NADPH (100 µm), and DMSO (1% (v/v)). The reaction was followed by measuring the absorbance 
at 340 nm (εNADPH, 340 nm = 6.22 mm−1 cm−1).
Expression of Tat-PAMO in 96-well plates. All optical measurements (optical density, OD600; 
absorbance; fluorescence) were conducted on a SynergyMx micro­titer plate reader (BioTek 
Instruments, Inc., Winooski, VT) using appropriate plates purchased from Greiner Bio­One 
(Kremsmünster, Austria). Cells were routinely grown in 2 mL 96­square well plates (Waters, 
Milford, MA) covered with air­permeable AeraSeal Sealing Films (Excel Scientific, Victorville, CA). 
The plates were incubated in a Titramax 1000 shaker (Heidolph, Schwabach, Germany) at 1050 rpm. 
Pre­cultures were inoculated from master plates using a cryo­replicator (Enzyscreen, Haarlem, The 
Netherlands) into a 96­well plate containing AP5Amp (1 mL) medium in each well. The plate was 
incubated at 30 °C for ~22 h. Afterwards, 60 µL of each pre­culture was diluted in fresh AP5Amp 
(800 µL) pre­warmed to 37 °C and incubated at 37 °C for 110–120 min until the cultures reached 
the OD600 of 0.4–0.5. Then l­arabinose (40 µL of 4% (w/v) solution) was added to the cultures along 
with FAD (9 µL of 1 mm solution). The plate was incubated at 37 °C for 16 h.
Screening procedure. After overnight expression of Tat­PAMO, cells were pelleted by centrifugation 
for 20 min at 2250 × g at 4  °C and resuspended in reaction mixture (250 µL) which contained: 
NADPH (20 µm), sodium phosphite (20 mm), 1,4­dioxane (1% (v/v)), sodium cyanide (20 mm), 
Peroxy Green 1 (250 µm), PTDH (5 µm), FAD (10 µm), Tris­HCl (50 mm, pH 9.0), and glycerol 
(10  mm). Afterwards, 10 µL of benzyl phenyl sulfide (0.125  m) was dispensed into each well. 
In the case of activity assays with phenylacetone, the reaction mixture contained: substrate (10 mm), 
NADPH (50 µm), sodium cyanide (20 mm), Peroxy Green 1 (250 µm), PTDH (5 µm), FAD (10 µm), 
Tris­HCl (50 mm, pH 7.5), and glycerol (10 mm). Reactions with phenylacetone were conducted 
for 1.5 h at 37 °C, 1050 rpm. In the case of benzyl phenyl sulfide, the reaction time was 1.5 or 3 h. 
Subse quently, the plate was centrifuged for 5 min at 2250 × g at 4 °C. 100 µL of the supernatant was 
used to measure the fluorescence. Excitation was at 460 nm, and emission was recorded at 510 nm 
while the sensitivity was set to 45. Mutants presenting at least 80% of the fluorescence emitted by 
the Q152F/L153G/M446G mutant were regarded as the uncoupling mutants and not considered 
for further analysis. For the quantification of phosphate, the supernatant (20 µL) was mixed with 
the molybdate reagent (200 µL), followed by the addition of ascorbic acid (50 µL). After 30 min 
incubation at 30 °C and 900 rpm, absorbance was read at 850, 700, and 600 nm. Phosphate standards 
containing potassium dihydroxy phosphate (from 0.2 to 10 mm) were used to prepare the calibration 
curve for the molybdate assay. The Z’­factor was used as a measure of the quality of the assay during 
the optimisation, and it was cal culated according to the formula introduced by Zhang et al. (1999):
𝑍𝑍’ = 1 −  3𝜎𝜎+ + 3𝜎𝜎−|µ+ − µ−|  
in which µ+ and µ− denote means of positive and negative control, respectively, and σ+ and σ− denote 
standard deviations.
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Whole-cell activity measurements. In order to evaluate the phosphate as a reporter of the BVMO 
activity, the Baeyer–Villiger product formed by Tat­PAMO cells was quantified by means of GC. 
To this end, wild­type and R337A Tat­PAMO cells were grown in 96­well plates and the protein 
expression was induced with l­arabinose. Harvested cells were resuspended in Tris­HCl (50 mm, 
pH 7.5) with glycerol (10 mm) and transferred to 2 mL glass screw cap vials (Brown Chromatography 
Supplies, Wertheim, Germany). Then phenylacetone and other reaction mixture components were 
added to the vials at the same concentrations as used in the screening, except that in half of the 
samples, PTDH was replaced with the buffer. After 90 min conversion at 37 °C, vials were spun 
down. 20 µL of the supernatant was used for the phosphate determination in the molybdate assay, 
while 200 µL of the supernatant were extracted with tert­butyl methyl ether (400 µL), dried over 
MgSO4 and separated on an AT5 column (30 m × 0.25 mm × 0.25 µm, Grace, Deerfield, IL) using 
the following temperature program: 2 min at 100 °C, 5 °C/min up to 120 °C, 20 °C/min up to 160 °C. 
Retention times of phenylacetone and benzyl acetate were 6.96 min and 7.45 min, respectively. 
Characterisation of the mutants. Plasmids of clones selected in the first round of screening were 
isolated. The plasmid DNA was used to transform fresh E. coli TOP10 cells, and the new clones 
were retested using the same assay. Clones with confirmed activity were expressed in TB (50 mL) 
and the proteins were purified using Ni Sepharose High Performance. 1 mL reactions containing 
PAMO mutant (4 µm), PTDH (4 µm), NADPH (200 µm), benzyl phenyl sulfide (5 mm), sodium 
phosphite (20 mm), Tris­HCl (50 mm, pH 9.0) were incubated at 30 °C for 48 h. Afterwards, they 
were extracted with ethyl acetate, dried over MgSO4 and analysed by GC on an HP1 column (30 m 
× 0.32 mm × 0.25 µm, Agilent, Santa Clara, CA) using the following temperature program: 5 min 
at 100 °C, 5 °C/min up to 200 °C, 5 min at 200 °C. Retention times were 20.9 min, 25.6 min, and 
26.2  min for the substrate, the sulfoxide, and the sulfone, respectively. The enantiomeric excess 
(ee) of the product was estimated by evaporating the samples, dissolving them in n­heptane/
isopropanol (9:1) and separating in chiral HPLC on a Chiralcel OD column (0.46  cm × 25 cm, 
Daicel, Japan) using isocratic n­heptane/isopropanol (9:1), flow 0.6  mL/min, 45 min, 40 °C. The 
(R)­enantiomer was eluted at 29 min and the (S)­sulfoxide at 32 min. ThermoFAD measurements 
were performed as described before (Dudek et al., 2011).
Results
Expression of PAMO in the periplasm
We sought to develop a generic screening procedure for NAD(P)­dependent 
enzymes based on whole cells, using PAMO as a model BVMO. In order to be 
successful, this system should offer unrestricted access of the enzyme towards the 
substrate tested. Unfortunately, many (potential) substrates are unable to cross 
the cytoplasmic membrane and, therefore, cannot react with the target enzyme 
expressed in the cytoplasm. Several strategies have been applied to increase sub­
strate accessibility. Secretion of the target enzyme out of the cyto plasm to the peri­
plasm is one of the typical approaches. The Tat pathway is the only one among 
bacterial translocation system that is capable of trans porting fully folded and often 
cofactor­containing proteins to the periplasm and is, therefore, of considerable 
biotechnological importance (Lee et al., 2006). Considering that PAMO requires 
non­covalently bound FAD cofactor for its activity, we decided to study whether 
the Tat pathway could be employed for functionally transporting PAMO to the 
periplasm. To this end, PAMO was N­terminally fused to the Tat­dependent signal 
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sequence of the endogenous E. coli protein TorA (Weiner et al., 1998), resulting 
in Tat­PAMO. Subsequently, we determined the best conditions for periplasmic 
expression of Tat­PAMO. For this, Tat­PAMO was expressed in E. coli under con­
trol of an arabinose­inducible promoter using increasing amounts of arabinose at 
17 °C, 24 °C, or 37 °C. These cells were harvested and fractionated into sphero­
plast and periplasmic fraction. Of note, the spheroplast fraction contains the cyto­
plasmic and total membrane fractions. Next, we analysed the specific activities 
of these fractions using phenylacetone as a substrate (Figure 2). At 17  °C and 
24  °C, the highest activity towards phenylacetone was clearly observed in the 
spheroplast fraction relative to the periplasmic fraction regardless of the arab­
inose concentration. However, at 37 °C the differences in the observed activities 
between the different fractions became less pronounced. In particular, a slightly 
higher specific activity for phenylacetone was observed in the periplasmic frac­
tion derived from cells induced for Tat­PAMO expression with 0.0002% arabinose 
relative to the spheroplast fraction prepared from the same cells. This indicates 
that PAMO was indeed for a  significant part translocated to the periplasm.
Although our data show that attachment of the TorA signal sequence does 
not inactivate PAMO, it cannot be excluded that this compromises the enzyme to 
some extent. Therefore, we decided to analyse the properties of PAMO isolated 
from a periplasmic preparation in more detail. Firstly, we found that the enzyme 
obtained from a periplasmic preparation runs at the same position in SDS­PAGE 
as native PAMO expressed in the cyto plasm, indicating that the TorA signal 
sequence is proteo lyt ically removed during periplasmic export as shown for other 
Tat­dependently exported proteins (Lee et al., 2006). Secondly, the kcat and KM 
Figure 2. Specific activity of periplasmic and spheroplast fractions of PAMO towards phenylacetone. 
E. coli cells expressing Tat­PAMO were fractionated into periplasm and spheroplast fractions. The 
concentrations of arabinose and temperatures used for the expression of Tat­PAMO are detailed.
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values for phenylacetone of PAMO expressed in the periplasm did not differ from 
the kinetic parameters of wild­type PAMO. Lastly, the apparent melting tempera­
ture of the mature­sized periplasmic form measured by the ThermoFAD method 
(Forneris et al., 2009) was the same as of wild­type PAMO (60 °C). This confirms 
that the function of PAMO is not affected by fusing it to the TorA signal sequence.
Culture conditions
Subsequent experiments aimed at optimising the conditions for the periplasmic 
export of PAMO. To this end, we developed an activity­based assay in 96­well 
plate format revolving around phosphate detection. After evaluating different 
growth media for our screening method, we obtained the best results with a mod­
ified version of AP5, a defined, low­phosphate medium (Chang et al., 1987). The 
phosphate content in this medium was found to be only ~0.3 mm compared to, 
for example, ~4 mm in LB medium. The low amount of phosphate in AP5 ensures 
low back ground signals without the need of washing cells before the activity assay. 
Importantly, the growth of E. coli is not severely inhibited by the limited amount 
of phosphate in liquid AP5 medium as evidenced by the optical density of 2.5–3 
when cells are grown to saturation in AP5 (Figure 3A).
In order to effectively control the growth of cells in individual wells, the opti­
mised protocol involved growing pre­cultures inoculated with cells from a glyc­
erol stock or fresh transformants. The pre­cultures were then diluted in fresh 
AP5 medium and grown for a given time before arabinose was added to induce 
the production of Tat­PAMO. Previously, we assessed several critical factors that 
control the reproducible expression of PAMO, and we observed that the cellu­
lar growth stage at which induction is initiated is of crucial importance for good 
overexpression (van Bloois et al., 2012). Therefore, we also determined the best 
induction time for the expression of Tat­PAMO. Furthermore, in the case of peri­
plasmic expression, the amount of the protein in the periplasm depends not only 
on the overall expression level but also on the efficiency of the export to the peri­
plasm. In other words, the highest total expression level may not correspond to 
the highest periplasmic expression. Therefore, we evaluated the induction proto­
col by measuring the whole­cell activity of Tat­PAMO cells with the phosphate 
assay. The highest activity was observed when cells were induced during the early 
exponential phase (Figure 3B). Since we observed a clear peak in activity depend­
ing on the growth phase, care had to be taken in order to induce the cells always in 
the same growth phase. We achieved this by using high volume inocula, medium 
pre­warmed to 37 °C, and precise culturing times.
We analysed whether external addition of FAD would improve the activity of the 
enzyme because it cannot be excluded that the enzyme partially loses its cofactor 
when it is placed in the environment lacking any free FAD such as the periplasm. 
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Figure 3. (A) Growth curve of E. coli cells transformed with the Tat­PAMO expression plasmid 
grown in AP5 medium in 96­well plate format. (B) The activity of the cells expressing Tat­PAMO 
depends strongly on the growth phase at which the protein expression is induced. Each point is 
an average of four measurements. Error bars indicate standard deviation. (C) Phosphate determi­
nation in samples of the inactive mutant Tat­PAMO R337A (0.4 mm phosphate) and wild­type 
Tat­PAMO (3.5 mm phosphate) after the reaction with phenylacetone.
Therefore, we tested several conditions in which 10 or 100 µm FAD was added to 
the culture medium during the expression and/or to the reaction medium during 
the biotrans formation. Surprisingly, we observed that the activity of Tat­PAMO 
can be doubled by adding 10 µm FAD during both the expression and the biotrans­
formation. This indeed suggests that PAMO partially loses FAD in the periplasm.
95
Screening method for Baeyer–Villiger monooxygenases
Coenzyme regeneration system
We have previously reported on an elegant system for coenzyme regeneration 
suitable for BVMOs by fusing them to PTDH (Torres Pazmiño et al., 2008; Torres 
Pazmiño et al., 2009). We sought to use the same coenzyme regeneration system 
for the design of our screening method. Under normal condi tions, namely no 
phosphate limitation, phosphite does not enter the cytoplasm of E. coli because 
pathways for assimilation of alter native phosphorus forms are repressed (Metcalf 
and Wanner, 1991; Wanner, 1993). However, under these conditions, phosphite 
is most likely able to cross the outer membrane and enter the periplasmic space. 
Export of PTDH to the periplasm is, therefore, required to enable efficient cofac­
tor recycling in this cellular compartment. However, appending PTDH to the 
N­terminus of Tat­PAMO impaired Tat­mediated transport of this fusion protein 
(data not shown). Therefore, we decided to use the established peri plasmic expres­
sion of PAMO in combination with externally added PTDH since NADP(H) 
can diffuse into and out of the peri plasm through the outer membrane pores. 
To facilitate over expression and purification, PTDH was sub cloned into the pBAD 
vector with an N­terminal His­tag. It could be purified on Ni2+­resin yielding up 
to 600 mg of protein per 1 L medium. In this way, the export of PAMO was not 
compromised by addition of the fusion partner. Furthermore, by adding isolated 
PTDH to the reactions, the concentration of the enzyme can be manipulated. 
Phosphate detection in molybdate assay
Methods commonly used for quantification of inorganic phosphate employ 
ammonium molybdate that reacts with phosphate to form a chromophore. 
These methods are typically modifications of a procedure published by Fiske 
and Subbarow (1925), and they require the use of strong acids which is not com­
patible with biological samples. Therefore, we adapted a method of Saheki et al. 
which was developed for assaying biological samples and is performed in slightly 
acidic conditions (Saheki et al., 1985). In this method, the phospho molyb date 
complex is reduced by ascorbic acid in the presence of Zn2+ ions, which leads to 
the formation of a blue product with an absor bance maximum at around 850 nm. 
As compared to the protocol of Saheki et al., we decreased the ammonium molyb­
date concentration from 15 to 10 mm and increased the time of incubation at 30 °C 
from 15 to 30 min. The colour formed is stable for at least 1 h. We down­scaled 
the procedure to make it compatible with 96­well plate format. A linear depend­
ence between the phosphate concentration and the absorbance was observed up 
to 4 mm phosphate. For phosphate concentrations higher than 4 mm, the absorb­
ance exceeded the detection limit. By shifting the detection wavelength to 600 nm, 
we extended the working range of the assay up to 10 mm phosphate. If required, 
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active and inactive clones can be distinguished by direct visual inspection, as pre­
sented in Figure 3C.
Control of the uncoupling
It has been observed for BVMOs that in the absence of a suitable substrate, the 
peroxyflavin intermediate can decay forming hydrogen peroxide (Torres Pazmiño 
et al., 2008). In this way, a BVMO can act as an NADPH oxidase. This process, 
referred to as uncoupling, is unfavourable in our screening for two reasons. First, 
mutants with high uncoupling rate may give high signals in the screening while 
they perform the desired conversion at low rate or are completely inactive in the 
Baeyer–Villiger reaction. Thus, uncoupling may result in the isolation of false posi­
tive clones in our NADPH­consumption­based screening system. Second, enzymes 
presenting increased uncoupling rates, even when they are still able to catalyse the 
reaction, work less efficiently because of the elevated coenzyme requirements and 
often reduced catalytic rates. Meanwhile, mutations introduced in the active site 
of the enzyme in order to alter its catalytic properties may affect the stability of 
the peroxyflavin, thereby increasing the uncoupling rate. These reasons prompted 
us to include hydrogen peroxide detection in order to increase the fidelity of our 
method. To this end, we decided to test Peroxy Green 1. It has been established 
that this dye is a highly specific probe for hydrogen peroxide (Miller et al., 2007). 
In the presence of hydrogen peroxide, the boronate moiety is cleaved off lead­
ing to the formation of fluorescent 2­methyl­4­O­methyl Tokyo Green (Figure 4). 
For establishing the conditions of the fluorescence measurements, we selected 
the previously characterised Q152F PAMO mutant (Dudek et al., 2011) and the 
triple Q152F/L153G/M446G PAMO mutant (Torres Pazmiño et al., 2007). Both 
mutants exhibit high uncoupling rates (0.5–0.6 s−1) relative to wild­type PAMO 
(0.02 s−1, Torres Pazmiño et al., 2008). These mutations were subsequently intro­
duced in Tat­PAMO. We found out that the cells producing these Tat­PAMO 
variants show Peroxy Green 1 based fluorescence values higher than wild­type 
Figure 4. Hydrogen peroxide reacts with Peroxy Green 1 leading to fluorescent 2­methyl­4­O­
methyl Tokyo Green.
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Tat­PAMO only if catalase activity is inhibited by adding sodium cyanide to the 
reaction medium. Conceivably, the increased amounts of hydrogen peroxide pro­
duced in these cells induce the expression of catalase activity. Nevertheless, in the 
presence of Peroxy Green 1 and sodium cyanide, a clear increase in the fluores­
cence emitted by the uncoupling mutant as compared to wild­type PAMO was 
observed. Furthermore, addition of Peroxy Green 1 or sodium cyanide did not 
interfere with the phosphate detection. These findings show that Peroxy Green 1 
can be incorporated in the phosphate screening method for efficient hydrogen per­
oxide detection, which allows elimination of variants with high uncoupling rates.
Evaluation of the screening method
After having established the best conditions for the expression of Tat­PAMO and 
the conditions for our screening method, we tested whether this optimised proto­
col could be used in a reproducible way to distinguish cells expressing the previ­
ously described PAMO R337A mutant from cells expressing wild­type PAMO, 
using phenyl acetone as substrate. The R337A mutant is inactive in Baeyer–Villiger 
reaction and consumes NADPH at a very low rate (0.001 s−1, Torres Pazmiño 
et al., 2008). To this end, we inoculated 32 wells with single colonies of E. coli cells 
transformed with a Tat­PAMO expression plasmid and 32 wells with cells har­
bouring a Tat­PAMO­R337A expression plasmid. Each of these pre­cultures was 
subsequently used to inoculate an expression culture which was then assayed for 
BVMO activity as described in Materials and Methods. The amounts of phosphate 
produced by each culture are shown in Figure 5A. In the control reaction of wild­
type PAMO, the mean signal of 5.0 mm was obtained while the background signal 
given by the inactive mutant R337A was only 0.54 mm (Table 1). This background 
signal can be caused by NADPH­consuming enzymes released from lysed cells. 
Relative standard deviations calculated from these data did not exceed 12%, which 
is a satis factory value for a whole­cell­based system. Furthermore, these data cor­
respond to a Z’­factor value of 0.6 which indicates very good separation of the 
signals and confirms the reliability of our screening method (Zhang et al., 1999).
Encouraged by these results, we used the same experimental set­up to test 
whether our method could be used to distinguish cells expressing the PAMO 
mutant M446G from cells expressing the R337A variant using benzyl phenyl 
sulfide as a substrate. This prochiral bulky compound is not converted by wild­
type PAMO while the M446G mutant has been shown to oxidise it to the cor­
responding sulfoxide (Dudek et al., 2011). In order to compensate for the low 
conversion rate, the reaction was performed at pH 9.0, at which the activity of 
PAMO is increased relative to pH 7.5. 1,4­dioxane at a concentration of 6% (v/v) 
was present in the reaction mixture in order to facilitate the solubilisation of the 
substrate. This amount of organic solvent did not inactivate either PAMO or 
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PTDH. The reaction was con ducted for 90 min. As shown in Figure 5B, the signals 
given by the M446G mutant can be clearly distinguished from the back ground sig­
nals. Not surprisingly, the separation band is smaller than in our previous control 
reaction of the wild­type enzyme with phenylacetone, but this reaction reflects 
better the situation of screening for activity on a challenging substrate. The rela­
tive standard deviations were at the level of 11–12% while the calculated Z’­factor 
value was 0.3 (Table 1), indicating that the method still allows accurate screening.
Figure 5. Phosphate signals obtained in independent replicates of the reaction of (A) wild­type 
PAMO and the R337A mutant with phenylacetone and (B) the M446G and R337A mutants with 
benzyl phenyl sulfide. The data points are plotted in descending order.
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In order to verify whether the measured phosphate levels correspond to the 
actual product formation, we employed GC for the quantification of the Baeyer–
Villiger product in parallel with phosphate measurements. Due to the adsorption 
of both phenylacetone and benzyl acetate onto plastic, we used glass vials mim­
icking the conditions in wells of a 96­well plate. 5.0 ± 0.8 mm of benzyl acetate 
was produced by Tat­PAMO cells in the presence of the coenzyme regeneration 
system as determined by GC analysis. Control experiments in the absence of the 
regeneration system showed that only traces of benzyl acetate (< 0.1 mm) were 
detected. This indicates that Baeyer–Villiger activity of Tat­PAMO cells is related 
to the periplasmic fraction of the enzyme, which is dependent on the external 
coenzyme regeneration. When the same samples were analysed using the phos­
phate detection assay, 5.4 ± 1.2 mm of phosphate was measured. Only 0.6 ± 0.2 mm 
of phosphate is produced by the R337A variant in this reaction, while no oxidised 
product was detected by GC analysis. This indicates that coenzyme recycling 
drives the production of about 4.8 mm phosphate by a  BVMO, demon strating 
the effectiveness of our coenzyme regeneration system. Thus, the obtained val­
ues of phosphate and benzyl acetate production under the assay conditions are 
within 10% of each other. These results confirm the applicability of phosphate as 
a reporter of BVMO activity in our system.
 
Table 1. Reproducibility of the screening method. Phosphate levels (mm) obtained for positive and 
negative control strains in reactions with phenyl acetone and benzyl phenyl sulfide are presented 
(SD, standard deviation; RSD, relative standard deviation).
Screening libraries of PAMO
The ability of our screening method to distinguish active PAMO variants from 
inactive ones demonstrates proof of principle. Therefore, the screening method 
was applied in screening of two site­saturation libraries of Tat­PAMO. In these 
libraries, the positions I67 or M446 were randomised, and for both libraries, 
91 randomly picked clones were assayed. The libraries were tested for activity 
with benzyl phenyl sulfide, which is poorly accepted by wild­type PAMO (Dudek 
et al., 2011). In the screening of the M446X library, a reaction time of 90 min was 
applied, and clones producing at least 1.4 mm phosphate were considered as active. 
To minimise false positive hits, we excluded clones displaying the fluorescence of 
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at least 80% of the Q152F/L153G/M446G mutant. Using these threshold values, 
eight active clones were isolated from the M446X library. Out of these hits, the pre­
viously characterised M446G variant was found seven times, while also a M446A 
mutant was found. To analyse the properties of the newly found M446A mutant 
in more detail, both enzymes were isolated and their reactivity towards benzyl 
phenyl sulfide was tested. The M446A mutant proved to convert this substrate 
with higher efficiency than the M446G variant (70% conversion in the case of 
M446A and 59% conversion in the case of M446G) and similar excellent enantio­
selectivity, leading to the (R)­sulfoxide as the main product (in both cases more 
than 98% ee). The I67X library was screened using less stringent threshold val­
ues, since initial experiments showed overall lower activity among mutants in this 
library. Therefore, a reaction time of 3 h was applied, and clones producing at least 
0.8 mm phosphate were further analysed. Under these conditions, eleven clones 
were isolated, and ten of these were found to be the I67S variant whereas I67T 
was obtained once. Both mutants were purified and their reacti vity towards ben­
zyl phenyl sulfide was studied. While the ability of I67T to convert benzyl phenyl 
sulfide was reported before (Dudek et al., 2011), the I67S mutant also produced 
the sulfoxide with high enantio meric excess (98% ee for the (S)­enantiomer).
We also picked several clones displaying highest fluorescence (NADPH oxi­
dase activity) in each library. It turned out that all four uncoupling clones selected 
from the I67X library were I67P mutants. Three uncoupling mutants from the 
M446X library contained a M446W mutation. These mutations, that is, the intro­
duction of a bulky residue at position 446 or a proline instead of an isoleucine at 
position 67, are indeed expected to perturb the active­site architecture, resulting 
in uncoupling mutants, which, thereby, further confirms the accuracy and the 
reliability of our screening method.
Discussion
Directed evolution experiments often lead to the conclusion that the screening 
conditions should reflect as much as possible the real conditions under which 
the reaction is to be performed. Use of surrogate or labelled substrates may result 
in identification of mutants less active on the target compound or not active at 
all. Furthermore, activity assays are often based on the particular property of 
a substrate or a product and thus need to be established for each compound. 
This underscores the need for a generic screening procedure applicable to a given 
class of enzymes and which is compatible with unmodified substrates. 
BVMOs can perform different types of oxidations: Baeyer–Villiger oxidation, 
sul foxi dation, epoxidation, and oxidation of heteroatoms like nitrogen, boron, and 
selenium (Balke et al., 2012; Leisch et al., 2011). A truly generic method for this 
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class of enzymes would enable screening for all these different activities. Therefore, 
a generic method can be related to oxygen or NADPH consumption by BVMOs 
during catalysis. However, accurate measurements of oxygen depletion would be 
difficult to perform in a high­throughput manner because oxygen diffuses easily, 
and a tight closure of the reaction system would be required. Moreover, oxygen is 
consumed by cellular metabolism, which would interfere with a whole­cell activ­
ity screening method based on oxygen consumption. On the other hand, follow­
ing NADPH depletion is a routinely used activity assay for BVMOs. In order to 
apply this method for screening libraries of mutants, cell extracts need to be pre­
pared first because there are no transporters for NADPH in the cell membrane. 
Lysing cells is a time­ and labour­consuming step. Moreover, cellular NADPH­
dependent enzymes are released, which interferes with the measurement, and 
high expression levels or high activities of the targeted enzyme are necessary to 
reliably detect its activity in the cell extract. Lastly, the absorbance spectrum of 
NADPH overlaps with spectra of many potential substrates, which would hamper 
accurate determination of NADPH.
Here we have addressed the above­mentioned issues and have developed 
a generic, whole­cell­based procedure suitable for screening BVMOs in 96­well 
plate format. Our method revolves around periplasmic expression of the target 
enzyme in E. coli because periplasmic location offers unrestricted access of the 
the substrate to the enzyme, as has been shown in previous studies (Sroga and 
Dordick, 2001). Additionally, directing the enzyme outside the cytoplasm helps 
to separate the activity of interest from cytoplasmic enzymes which can interfere 
with the activity assay. Based on the cofactor require ments of PAMO, we decided 
to use the Tat pathway for peri plasmic transport. Our data indeed show that 
PAMO is trans ported to the periplasm in a functional form. Importantly, PAMO 
is the first flavoprotein monooxygenase expressed functionally in the periplasm.
Moreover, periplasmic expression of PAMO enables efficient coenzyme recy­
cling by the established PTDH­based regeneration system (Torres Pazmiño et al., 
2008; Torres Pazmiño et al., 2009), using externally added PTDH. We were able to 
detect and quantify the phosphate released by this system during NADPH regen­
eration in a colorimetric reaction with molybdate (Saheki et al., 1985), allowing 
the use of the released phosphate as a reporter of BVMO activity. In this way, we 
could accurately measure BVMO activity using whole­cells. The method allows 
end­point measurements and the detected phosphate amount corresponds to 
the amount of the oxidation product. Although it is possible to spectrophoto­
metrically observe NADPH consumption by E. coli cells expressing PAMO in 
the periplasm, the accuracy is affected by light­scattering effects of cells. Here, by 
using indirect measurements of NADPH depletion, we can move the detection to 
the visible range and use high cell densities. Employing the regeneration system 
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further increases the sensitivity of the method because the amount of phosphate 
can build up during multiple turnovers. This principle could also be applied to 
cell extracts, but in this case, the background would be much higher because of 
cellular NADPH­consuming enzymes.
BVMOs are known to produce hydrogen peroxide in the absence of a suit­
able substrate while consuming NADPH. This form of non­productive catalysis 
is undesirable in our screening method because it increases the number of false 
positive hits. While in wild­type PAMO uncoupling occurs at a low rate (Torres 
Pazmiño et al., 2008), this reaction can be promoted by mutations introduced in 
the active site during creating libraries. To increase the accuracy of our screening 
method, we included an additional control reaction to monitor the formation of 
hydrogen peroxide. To this end, we successfully used Peroxy Green 1, a fluores­
cent dye highly specific for hydrogen peroxide (Miller et al., 2007). It is worth not­
ing that our work represents the first example of using Peroxy Green 1 in mutant 
library screening.
We showed that the procedure enables distinguishing between active PAMO 
variants and inactive variants and that the amount of phosphate produced during 
biotransformation is in agreement with the amount of the oxidation product. This 
clearly demonstrated proof of principle, thereby validating our method and con­
firming its robustness. Subsequently, two site­saturation libraries of Tat­PAMO, 
randomised at positions I67 or M446, were successfully screened using our pro­
tocol, resulting in the identification of two novel PAMO variants with interesting 
enantio selectivities. Notably, screening of other libraries using this procedure is 
currently on­going in our laboratory. 
Our newly developed method offers the advantage of screening for the activity 
towards unmodified substrates. In fact, the same protocol can be employed for any 
potential substrate. In this report, we have used the method in screening for activ­
ity on phenylacetone and benzyl phenyl sulfide. These substrates undergo different 
reaction types, namely the Baeyer–Villiger oxidation and sulfoxidation. Since the 
enzyme is expressed in the periplasm, which is a weakly controlled cellular com­
partment, it is possible to screen for activity or stability in different reaction media 
(for instance, at pH different than neutral or in the presence of solvents). This 
points out to the flexibility of the protocol. Moreover, the applications of the new 
method are much broader than just screening for BVMO activity. In principle, 
the method can be applied in the screening of any NADPH­consuming enzyme. 
Moreover, since PTDH accepts both NADPH and NADH, this method can be 
used to screen for NADH­dependent enzymes as well, or it could be employed 
to evolve enzymes with altered coenzyme specificity. Even though the method 
is based on the general ability of enzymes to oxidise NADPH, it allows immedi­
ate elimination of variants catalysing unproductive cycles, generating hydrogen 
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peroxide. The established screening protocol is suitable for 96­well plates which 
obviously limits the throughput to several hundred clones per day. We are cur­
rently exploring options to translate the reported principle of screening to a higher 
throughput format, for example, by growing and screening colonies on agar plates.
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